Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postage Due: FDA Stamps Enforcement On Spiked Supplement Found In International Shipments

This article was originally published in The Tan Sheet

Executive Summary

Most products identified in public notifications contain weight loss or ED drugs, but two contained fluoxetine, for treating depression, bulimia and obsessive-compulsive, panic and premenstrual dysphonic disorders. Using personal mail for commercial shipments is some importers only chance of getting products in the U.S.

You may also be interested in...



FDA Reaps More Spiked Supplements From International Mail Shipments

FDA identifies 14 products in examinations of international mail shipments found to contain approved and banned drug ingredients indicated for weight loss, erectile dysfunction and depression.

Sales Grow Across C&D's Products And Regions, But Increasing Supply Costs Stunt Income

Raw material supplies slowed during January-March period by catastrophic freeze in Texas and shortage of shipping containers partly due to Suez Canal blockage. "We're absorbing $90 million of incremental costs for the full year,” says CFO Ronald Dierker.

Trade Groups Push US FDA To Close Window On Loosened OTC Sanitizer Production Standards

A day after FDA posted Scentsational’s recall announcement due to presence of benzene and acetaldehyde as well as methanol, American Cleaning Institute and Consumer Healthcare Products Association submit a letter urging FDA to restore order to OTC alcohol-based sanitizer market.

Topics

Related Companies

UsernamePublicRestriction

Register

PS107545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel